Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Shazad Mushtaq

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

scientific article published on November 2010

Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters

scientific article

Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms

scientific article published on September 15, 2010

Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

scientific article published on May 21, 2013

Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases

scientific article published on 25 August 2015

Activity of RX-04 Pyrrolocytosine Protein Synthesis Inhibitors against Multidrug-Resistant Gram-Negative Bacteria

scientific article published on 27 July 2018

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates

scientific article published on November 14, 2010

Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae

scientific article published on April 10, 2013

Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes

scientific article published on September 3, 2012

Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles

scientific article published on 16 May 2017

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci

scientific article

AmpC β-lactamase induction by avibactam and relebactam

scientific article published on 6 September 2017

Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis

scientific article

Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss

scientific article

Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104).

scientific article

Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria

scientific article

Detection of CTX-M-15 extended-spectrum beta-lactamase in the United Kingdom

scientific article

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

scientific article

Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance

scientific article published in October 2017

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

scientific article published on 04 April 2016

In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria

scientific article published on 3 February 2017

In vitro activity of cefiderocol, a siderophore-cephalosporin, against multidrug-resistant gram-negative bacteria

scientific article published on 21 September 2020

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters

scientific article published on August 26, 2010

In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.

scientific article published in March 2014

In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci

scientific article published on 8 January 2007

In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase

scientific article

Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants

scientific article

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases

scientific article published on 9 August 2008

Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline

scientific article published on 4 July 2015

Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases

scientific article published on June 13, 2011

Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens

scientific article published on 20 October 2017

Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014.

scientific article published on December 2016

Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae

scientific article published on January 26, 2011

Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint

scientific article published on 27 August 2015

Tigecycline activity: low resistance rates but problematic disc breakpoints revealed by a multicentre sentinel survey in the UK

scientific article published on October 7, 2010

WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases

scientific article published on 16 February 2017

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline

scientific article published on 22 March 2011